Editas Medicine, Inc. (EDIT)
NMS – Real Time Price. Currency in USD
2.83
-0.12 (-4.07%)
Market open: Aug 12, 2026, 2:32 PM EDT
2.94
-0.01 (-0.34%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
2.83
-0.12 (-4.07%)
Market open: Aug 12, 2026, 2:32 PM EDT
2.94
-0.01 (-0.34%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $181.8M significantly exceed its total debt $71.2M, ensuring strong financial flexibility
Total current assets $218.1M exceed Total current liabilities $68.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.7) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-18.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$29.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.19 | 6.05 | 10 | |
| Quick ratio | 3.19 | 5.63 | 10 | |
| Debt to Equity | 0.68 | 0.30 | 7.0 | |
| Debt to Assets | 0.30 | 1.04 | 7.0 | |
| Interest coverage | -18.75 | -16.91 | 1.0 | |
| Weighted average score | 7.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 20M | 78M | 32M | 41M | 47M |
| Gross Profit | 13M | 72M | 27M | 35M | 45M |
| Operating Income | -226M | -169M | -239M | -99M | -83M |
| Net Income | -220M | -153M | -237M | -160M | -74M |
| EBITDA | -220M | -163M | -233M | -94M | -81M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -49.85 | 27.14 | 5.5 |
| Next quarter | -74.99 | -214.68 | 1.0 |
| Current year | -41.18 | 57.11 | 5.5 |
| Next year | -17.74 | 10.5 | 4.0 |
| Weighted average score | 4.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 319.99 | 27.03 | 42.31 | -28.15 | 7.8 |
| Y/Y | 232.31 | 65.76 | 76.19 | 40.9 | 10 |
| 3y average | 87.69 | 2.75 | 10.67 | -3.71 | 5.5 |
| 5y average | 33.68 | -14.43 | -4.9 | -1.72 | 3.3 |
| Weighted average score | 6.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |